A Fortune 200 pharmaceutical company retained our firm to oversee the 2013 review of the company’s data security policies and procedures related to new healthcare data reporting services. Our professionals worked to ensure compliance under applicable U.S. and EU statutes and regulations.
2013
Pharmaceutical Company Reviews Data Security Policies to Comply With U.S. and EU Law
North America - United States | Europe
Lead Contacts
